Abstract
The generation of dopamine (DA) neurons from stem cells holds great promise for future biomedical research and in the clinical treatment of neurodegenerative diseases, such as Parkinson’s disease. Mesenchymal stem cells (MSCs) derived from the adult human bone marrow (BM) can be easily isolated and expanded in culture while maintaining their immense plasticity. Here, we describe a protocol to generate DA-producing cells from adult human MSCs using a cocktail that includes sonic hedgehog (SHH), fibroblast growth factor 8 (FGF8), and basic fibroblast growth factor (bFGF). Electrophysiological functional DA neurons could be achieved by further treatment with brain-derived neurotrophic factor (BDNF). In summary, a protocol is described for the induction of primary BM-derived human MSCs to specific transdifferentiation; in this case, functional DA neurons. The MSC-derived DA cells express DA-specific markers, synthesize, and secrete dopamine. The described method could be used to generate DA cells for various model systems in which DA-producing cells are implicated in pathophysiological conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Picinich, S.C., Mishra, P.J., Mishra, P.J., Glod, J., Banerjee, D. (2007) The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opin Biol Ther 7, 965–73.
Zipori, D. (2004) Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair. Blood Cells Mol Dis 33, 211–5.
Giordano, A., Galderisi, U., Marino, I.R. (2007) From the laboratory bench to the patient’s bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 211, 27–35.
Phinney, D.G., Isakova, I. (2005) Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des 11, 1255–65.
Bianco, P., Riminucci, M., Gronthos, S., Robey, P.G. (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19, 180–92.
Potian, J.A., Aviv, H., Ponzio, N.M., Harrison, J.S., Rameshwar, P. (2003) Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171, 3426–34.
Krampera, M., Pasini, A., Pizzolo, G., Cosmi, L., Romagnani, S., Annunziato, F. (2006) Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr Opin Pharmacol 6, 435–41.
Greco, S.J., Zhou, C., Ye, J.H., Rameshwar, P. (2007) An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev 16, 811–26.
Tropel, P., Platet, N., Platel, J.C., Noel, D., Albrieux, M., Benabid, A.L., Berger, F. (2006) Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. Stem Cells 24, 2868–76.
Sato, Y., Araki, H., Kato, J., Nakamura, K., Kawano, Y., Kobune, M., Sato, T., Miyanishi, K., Takayama, T., Takahashi, M., Takimoto, R., Iyama, S., Matsunaga, T., Ohtani, S., Matsuura, A., Hamada, H., Niitsu, Y. (2005) Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 106, 756–63.
Zeng, X., Cai, J., Chen, J., Luo, Y., You, Z.B., Fotter, E., Wang, Y., Harvey, B., Miura, T., Backman, C., Chen, G.J., Rao, M.S., Freed, W.J. (2004) Dopaminergic differentiation of human embryonic stem cells. Stem Cells 22, 925–40.
Lindvall, O., Kokaia, Z., Martinez-Serrano, A. (2004) Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 10 Suppl, S42–50.
Correia, A.S., Anisimov, S.V., Li, J.Y., Brundin, P. (2005) Stem cell-based therapy for Parkinson’s disease. Ann Med 37, 487–98.
Trzaska, K.A., Kuzhikandathil, E.V., Rameshwar, P. (2007) Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 25, 2797–808.
Trzaska, K.A., King, C.C., Le, K.Y., Kuzhikandathil, E.V., Nowycky, M.C., Ye, J.H., Rameshwar, P. (2009) Functional maturation of mesenchymal stem cell-derived dopamine progenitors by brain-derived neurotrophic factor. J Neurochem 110, 1058–69.
Acknowledgments
This work has been supported by the F.M. Kirby Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Trzaska, K.A., Rameshwar, P. (2011). Dopaminergic Neuronal Differentiation Protocol for Human Mesenchymal Stem Cells. In: Vemuri, M., Chase, L., Rao, M. (eds) Mesenchymal Stem Cell Assays and Applications. Methods in Molecular Biology, vol 698. Humana Press. https://doi.org/10.1007/978-1-60761-999-4_22
Download citation
DOI: https://doi.org/10.1007/978-1-60761-999-4_22
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-998-7
Online ISBN: 978-1-60761-999-4
eBook Packages: Springer Protocols